Agios Pharmaceuticals

AGIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.927 B

$32.27 +1.00%

Close of 7 Aug 2026

Revenue

$54.0M

#2715 by revenue

Earnings

-$413.0M

Loss-making

Shares outstanding

59,701,882

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#114AbCellera BiologicsABCL$2.04B
#115Ocular TherapeutixOCUL$2.02B
#116Agios PharmaceuticalsAGIO$1.93B
#117COMPASS PathwaysCMPS$1.87B
#118NanobiotixNBTX$1.85B

Where these numbers come from

Share counts and financials for Agios Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.